Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Revance Therapeutics (RVNC) Ownership - Who Owns Revance Therapeutics?
554 Followers
Revance Therapeutics (RVNC) Ownership Overview
12.84% Insiders
33.94% Mutual Funds
48.58% Other Institutional Investors
4.64% Public Companies and
Individual Investors
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail and individual investors. Approximately 82.52% of the company’s stock is owned by Institutional Investors, 12.84% is owned by Insiders and 4.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 17, 2024 | Erica Jordan Chief Commercial Officer | Sold | $9090 |
| Mar 19, 2024 | Sold | $67436 | |
| Mar 19, 2024 | Dwight Moxie Clo & Gc | Sold | $58276 |
| Mar 19, 2024 | Dustin S Sjuts President | Sold | $62149 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $97937 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,730,357 | Institution | 6.44% | 22,277,482 | |
| 5,202,716 | Institution | 4.98% | 17,220,990 | |
| 5,026,711 | Institution | 4.81% | 16,638,413 | |
| 4,102,694 | Institution | 3.93% | 13,579,917 | |
| 4,070,716 | Institution | 3.90% | 13,474,070 | |
| 3,096,650 | Insider | 2.96% | 10,249,912 | |
| 3,096,650 | Insider | 2.96% | 10,249,912 | |
| 3,096,650 | Insider | 2.96% | 10,249,912 | |
| 2,480,152 | Institution | 2.37% | 8,209,303 | |
| 1,845,529 | Institution | 1.77% | 6,108,701 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,730,357 | Institution | 6.44% | 22,277,482 | |
| 5,026,711 | Institution | 4.81% | 16,638,413 | |
| 4,070,716 | Institution | 3.90% | 13,474,070 | |
| 2,480,152 | Institution | 2.37% | 8,209,303 | |
| 1,845,529 | Institution | 1.77% | 6,108,701 | |
| 1,623,916 | Institution | 1.55% | 5,375,162 | |
| 953,114 | Institution | 0.91% | 3,154,807 | |
| 937,554 | Institution | 0.90% | 3,103,304 | |
| 936,581 | Institution | 0.90% | 3,100,083 | |
| 905,194 | Institution | 0.87% | 2,996,192 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,094,072 | Institution | 2.96% | 11,169,600 | |
| 2,090,775 | Institution | 2.00% | 6,920,465 | |
| 1,363,106 | Institution | 1.31% | 4,920,813 | |
| 737,164 | Institution | 0.71% | 2,440,013 | |
| 673,775 | Institution | 0.65% | 2,230,195 | |
| 421,918 | Institution | 0.40% | 1,468,275 | |
| 335,053 | Institution | 0.32% | 1,209,541 | |
| 326,254 | Institution | 0.31% | 1,177,777 | |
| 318,964 | Institution | 0.31% | 1,109,995 | |
| 242,406 | Institution | 0.23% | 802,364 |
FAQ
Who Owns Revance Therapeutics (RVNC)?
According to the latest TipRanks data, approximately 48.58% of the company's stock is held by institutional investors, 12.84% is held by insiders, and 4.64% is held by retail investors.
What percentage of Revance Therapeutics (RVNC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.58% of Revance Therapeutics (RVNC) stock is held by institutional investors.
What percentage of Revance Therapeutics (RVNC) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.64% of Revance Therapeutics (RVNC) stock is held by retail investors.
Who owns the most shares of Revance Therapeutics (RVNC)?
SMALLCAP World Fund Inc owns the most shares of Revance Therapeutics (RVNC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.